FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:332-336 August 3, 2000 Number 5 Next

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article PubMed Citation

ABSTRACT

Background Although inhaled corticosteroids are effective for the treatment of asthma, it is uncertain whether their use can prevent death from asthma.

Methods We used the Saskatchewan Health data bases to form a population-based cohort of all subjects from 5 through 44 years of age who were using antiasthma drugs during the period from 1975 through 1991. We followed subjects until the end of 1997, their 55th birthday, death, emigration, or termination of health insurance coverage, whichever came first. We conducted a nested case–control study in which subjects who died of asthma were matched with controls within the cohort according to the length of follow-up at the time of death of the case patient (the index date), the date of study entry, and the severity of asthma. We calculated rate ratios after adjustment for the subject's age and sex; the number of prescriptions of theophylline, nebulized and oral ß-adrenergic agonists, and oral corticosteroids in the year before the index date; the number of canisters of inhaled ß-adrenergic agonists used in the year before the index date; and the number of hospitalizations for asthma in the two years before the index date.

Results The cohort consisted of 30,569 subjects. Of the 562 deaths, 77 were classified as due to asthma. We matched the 66 subjects who died of asthma for whom there were complete data with 2681 controls. Fifty-three percent of the case patients and 46 percent of the control patients had used inhaled corticosteroids in the previous year, most commonly low-dose beclomethasone. The mean number of canisters was 1.18 for the patients who died and 1.57 for the controls. On the basis of a continuous dose–response analysis, we calculated that the rate of death from asthma decreased by 21 percent with each additional canister of inhaled corticosteroids used in the previous year (adjusted rate ratio, 0.79; 95 percent confidence interval, 0.65 to 0.97). The rate of death from asthma during the first three months after discontinuation of inhaled corticosteroids was higher than the rate among patients who continued to use the drugs.

Conclusions The regular use of low-dose inhaled corticosteroids is associated with a decreased risk of death from asthma.

Source Information

From the Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University Health Centre, and the Departments of Epidemiology and Biostatistics and of Medicine, McGill University (S.S., P.E., S.B., M.B., B.C.); and the Division of Respiratory Medicine, McGill University Health Centre (P.E.) — all in Montreal.

Address reprint requests to Dr. Suissa at the Division of Clinical Epidemiology, Royal Victoria Hospital, 687 Pine Ave. West, Ross 4.29, Montreal, QC H3A 1A1, Canada, or at samy.suissa{at}clinepi.mcgill.ca.

Full Text of this Article

This article has been cited by other articles:

• Derom, E., Louis, R., Tiesler, C., Engelstatter, R., Kaufman, J-M., Joos, G. F. (2009). Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma. Eur Respir J 33: 1277-1286 [Abstract] [Full Text]  
• Lamb, D. A., Eurich, D. T., McAlister, F. A., Tsuyuki, R. T., Semchuk, W. M., Wilson, T. W., Blackburn, D. F. (2009). Changes in Adherence to Evidence-Based Medications in the First Year After Initial Hospitalization for Heart Failure: Observational Cohort Study From 1994 to 2003. Circ Cardiovasc Qual Outcomes 2: 228-235 [Abstract] [Full Text]  
• Wijesinghe, M., Weatherall, M., Perrin, K., Crane, J., Beasley, R. (2009). International Trends in Asthma Mortality Rates in the 5- to 34-Year Age Group: A Call for Closer Surveillance. Chest 135: 1045-1049 [Abstract] [Full Text]  
• Fanta, C. H. (2009). Asthma. NEJM 360: 1002-1014 [Full Text]  
• Baxter, J. D., Samnaliev, M., Clark, R. E. (2009). The Quality of Asthma Care Among Adults With Substance-Related Disorders and Adults With Mental Illness. Psychiatr. Serv. 60: 43-49 [Abstract] [Full Text]  
• Southam, D. S., Ellis, R., Wattie, J., Glass, W., Inman, M. D. (2008). Goblet Cell Rebound and Airway Dysfunction with Corticosteroid Withdrawal in a Mouse Model of Asthma. Am. J. Respir. Crit. Care Med. 178: 1115-1122 [Abstract] [Full Text]  
• Southam, D. S., Ellis, R., Wattie, J., Young, S., Inman, M. D. (2008). Budesonide prevents but does not reverse sustained airway hyperresponsiveness in mice. Eur Respir J 32: 970-978 [Abstract] [Full Text]  
• Smith, L. A., Bokhour, B., Hohman, K. H., Miroshnik, I., Kleinman, K. P., Cohn, E., Cortes, D. E., Galbraith, A., Rand, C., Lieu, T. A. (2008). Modifiable Risk Factors for Suboptimal Control and Controller Medication Underuse Among Children With Asthma. Pediatrics 122: 760-769 [Abstract] [Full Text]  
• Wilper, A. P., Woolhandler, S., Lasser, K. E., McCormick, D., Bor, D. H., Himmelstein, D. U. (2008). A National Study of Chronic Disease Prevalence and Access to Care in Uninsured U.S. Adults. ANN INTERN MED 149: 170-176 [Abstract] [Full Text]  
• McAlister, F. A., Eurich, D. T., Majumdar, S. R., Johnson, J. A. (2008). The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy. Eur J Heart Fail 10: 703-708 [Abstract] [Full Text]  
• Joos, S, Miksch, A, Szecsenyi, J, Wieseler, B, Grouven, U, Kaiser, T, Schneider, A (2008). Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review. Thorax 63: 453-462 [Abstract] [Full Text]  
• Mehuys, E., Van Bortel, L., De Bolle, L., Van Tongelen, I., Annemans, L., Remon, J. P., Brusselle, G. (2008). Effectiveness of pharmacist intervention for asthma control improvement. Eur Respir J 31: 790-799 [Abstract] [Full Text]  
• Suissa, S. (2008). Immortal Time Bias in Pharmacoepidemiology. Am J Epidemiol 167: 492-499 [Abstract] [Full Text]  
• Bateman, E. D., Hurd, S. S., Barnes, P. J., Bousquet, J., Drazen, J. M., FitzGerald, M., Gibson, P., Ohta, K., O'Byrne, P., Pedersen, S. E., Pizzichini, E., Sullivan, S. D., Wenzel, S. E., Zar, H. J. (2008). Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31: 143-178 [Abstract] [Full Text]  
• Skoner, D. P., Maspero, J., Banerji, D., and the Ciclesonide Pediatric Growth Study Group, (2008). Assessment of the Long-term Safety of Inhaled Ciclesonide on Growth in Children With Asthma. Pediatrics 121: e1-e14 [Abstract] [Full Text]  
• Nieto, A., Mazon, A., Pamies, R., Linana, J. J., Lanuza, A., Jimenez, F. O., Medina-Hernandez, A., Nieto, F. J. (2007). Adverse Effects of Inhaled Corticosteroids in Funded and Nonfunded Studies. Arch Intern Med 167: 2047-2053 [Abstract] [Full Text]  
• Mangione-Smith, R., DeCristofaro, A. H., Setodji, C. M., Keesey, J., Klein, D. J., Adams, J. L., Schuster, M. A., McGlynn, E. A. (2007). The Quality of Ambulatory Care Delivered to Children in the United States. NEJM 357: 1515-1523 [Abstract] [Full Text]  
• Cazzola, M., Matera, M. G. (2007). Review: Safety of long-acting {beta}2 -agonists in the treatment of asthma. Ther Adv Respir Dis 1: 35-46 [Abstract]  
• Suissa, S., McGhan, R., Niewoehner, D., Make, B. (2007). Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 4: 535-542 [Abstract] [Full Text]  
• Papi, A., Canonica, G. W., Maestrelli, P., Paggiaro, P., Olivieri, D., Pozzi, E., Crimi, N., Vignola, A. M., Morelli, P., Nicolini, G., Fabbri, L. M., the BEST Study Group, (2007). Rescue Use of Beclomethasone and Albuterol in a Single Inhaler for Mild Asthma. NEJM 356: 2040-2052 [Abstract] [Full Text]  
• Wechsler, M. E., Shepard, J.-A. O., Mark, E. J. (2007). Case 15-2007 -- A 20-Year-Old Woman with Asthma and Cardiorespiratory Arrest. NEJM 356: 2083-2091 [Full Text]  
• Butz, A. M., Tsoukleris, M., Donithan, M., Hsu, V. D., Mudd, K., Zuckerman, I. H., Bollinger, M. E. (2006). Patterns of Inhaled Antiinflammatory Medication Use in Young Underserved Children With Asthma. Pediatrics 118: 2504-2513 [Abstract] [Full Text]  
• Barnes, P. J. (2006). Treatment with (R)-Albuterol Has No Advantage over Racemic Albuterol.. Am. J. Respir. Crit. Care Med. 174: 969-972 [Full Text]  
• Barnes, P. J. (2006). Rebuttal by Dr. Barnes. Am. J. Respir. Crit. Care Med. 174: 974-974 [Full Text]  
• Halterman, J. S., Fisher, S., Conn, K. M., Fagnano, M., Lynch, K., Marky, A., Szilagyi, P. G. (2006). Improved preventive care for asthma: a randomized trial of clinician prompting in pediatric offices.. Arch Pediatr Adolesc Med 160: 1018-1025 [Abstract] [Full Text]  
• Schuh, S., Dick, P. T., Stephens, D., Hartley, M., Khaikin, S., Rodrigues, L., Coates, A. L. (2006). High-Dose Inhaled Fluticasone Does Not Replace Oral Prednisolone in Children With Mild to Moderate Acute Asthma. Pediatrics 118: 644-650 [Abstract] [Full Text]  
• Humbert, M. (2006). The Right Tools at the Right Time. Chest 130: 29S-40S [Abstract] [Full Text]  
• Williams, D. M. (2006). Considerations in the long-term management of asthma in ambulatory patients. Am J Health Syst Pharm 63: S14-S21 [Abstract] [Full Text]  
• Murray, C S, Poletti, G, Kebadze, T, Morris, J, Woodcock, A, Johnston, S L, Custovic, A (2006). Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 61: 376-382 [Abstract] [Full Text]  
• Lim, D L, Ma, S, Wang, X S, Cutter, J, Chew, S K, Lim, T K, Lee, B W (2006). Trends in sales of inhaled corticosteroids and asthma outcomes in Singapore.. Thorax 61: 362-362 [Full Text]  
• Scarfone, R. J., Zorc, J. J., Angsuco, C. J. (2006). Emergency Physicians' Prescribing of Asthma Controller Medications. Pediatrics 117: 821-827 [Abstract] [Full Text]  
• Lange, P, Scharling, H, Ulrik, C S, Vestbo, J (2006). Inhaled corticosteroids and decline of lung function in community residents with asthma. Thorax 61: 100-104 [Abstract] [Full Text]  
• Nelson, H. S., Weiss, S. T., Bleecker, E. R., Yancey, S. W., Dorinsky, P. M., the SMART Study Group, (2006). The Salmeterol Multicenter Asthma Research Trial: A Comparison of Usual Pharmacotherapy for Asthma or Usual Pharmacotherapy Plus Salmeterol. Chest 129: 15-26 [Abstract] [Full Text]  
• Strek, M. E. (2006). Difficult asthma.. Proc Am Thorac Soc 3: 116-123 [Abstract] [Full Text]  
• Miller, M., Cho, J. Y., McElwain, K., McElwain, S., Shim, J. Y., Manni, M., Baek, J. S., Broide, D. H. (2006). Corticosteroids prevent myofibroblast accumulation and airway remodeling in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L162-L169 [Abstract] [Full Text]  
• Schatz, M., Nakahiro, R., Crawford, W., Mendoza, G., Mosen, D., Stibolt, T. B. (2005). Asthma Quality-of-Care Markers Using Administrative Data. Chest 128: 1968-1973 [Abstract] [Full Text]  
• Eurich, D. T., Majumdar, S. R., McAlister, F. A., Tsuyuki, R. T., Johnson, J. A. (2005). Improved Clinical Outcomes Associated With Metformin in Patients With Diabetes and Heart Failure. Diabetes Care 28: 2345-2351 [Abstract] [Full Text]  
• O'Sullivan, S. M. (2005). Asthma Death, CD8+ T Cells, and Viruses. Proc Am Thorac Soc 2: 162-165 [Abstract] [Full Text]  
• Boushey, H. A., Sorkness, C. A., King, T. S., Sullivan, S. D., Fahy, J. V., Lazarus, S. C., Chinchilli, V. M., Craig, T. J., Dimango, E. A., Deykin, A., Fagan, J. K., Fish, J. E., Ford, J. G., Kraft, M., Lemanske, R. F. Jr., Leone, F. T., Martin, R. J., Mauger, E. A., Pesola, G. R., Peters, S. P., Rollings, N. J., Szefler, S. J., Wechsler, M. E., Israel, E., the National Heart, Lung, and Blood Institute's As, (2005). Daily versus As-Needed Corticosteroids for Mild Persistent Asthma. NEJM 352: 1519-1528 [Abstract] [Full Text]  
• Senthilselvan, A., Lawson, J. A., Rennie, D. C., Dosman, J. A. (2005). Regular Use of Corticosteroids and Low Use of Short-Acting {beta}2-Agonists Can Reduce Asthma Hospitalization. Chest 127: 1242-1251 [Abstract] [Full Text]  
• Hertzman, P. A., Kelly, H. W., Coultas, D. (2005). Chronic Illness Care in Russia: A Pilot Project To Improve Asthma Care in a "Closed City". Chest 127: 861-865 [Abstract] [Full Text]  
• Masoli, M, Weatherall, M, Beasley, R (2005). Optimal starting dose of inhaled corticosteroids in adult asthma: why has it taken so long?. Thorax 60: 93-94 [Full Text]  
• Jayaram, L, Pizzichini, E, Lemiere, C, Man, S F P, Cartier, A, Hargreave, F E, Pizzichini, M M M (2005). Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast. Thorax 60: 100-105 [Abstract] [Full Text]  
• Anderson, H R., Ayres, J. G, Sturdy, P. M, Bland, J M., Butland, B. K, Peckitt, C., Taylor, J. C, Victor, C. R, for the Mortality and Severe Morbidity Group of th, (2005). Bronchodilator treatment and deaths from asthma: case-control study. BMJ 330: 117- [Abstract] [Full Text]  
• Reddel, H.K. (2004). Goals of asthma treatment: how high should we go?. Eur Respir J 24: 715-717 [Full Text]  
• Tattersfield, A. E., Harrison, T. W., Hubbard, R. B., Mortimer, K. (2004). Safety of Inhaled Corticosteroids. Proc Am Thorac Soc 1: 171-175 [Abstract] [Full Text]  
• Suissa, S. (2004). From the authors. Eur Respir J 24: 711-711 [Full Text]  
• Colice, G. L. (2004). Categorizing Asthma Severity: An Overview of National Guidelines. Clin Med Res 2: 155-163 [Abstract] [Full Text]  
• Sin, D. D., Man, J., Sharpe, H., Gan, W. Q., Man, S. F. P. (2004). Pharmacological Management to Reduce Exacerbations in Adults With Asthma: A Systematic Review and Meta-analysis. JAMA 292: 367-376 [Abstract] [Full Text]  
• Stempel, D. A., Roberts, C. S., Stanford, R. H. (2004). Treatment Patterns in the Months Prior to and After Asthma-Related Emergency Department Visit. Chest 126: 75-80 [Abstract] [Full Text]  
• Eurich, D. T., Majumdar, S. R., Tsuyuki, R. T., Johnson, J. A. (2004). Reduced Mortality Associated With the Use of ACE Inhibitors in Patients With Type 2 Diabetes. Diabetes Care 27: 1330-1334 [Abstract] [Full Text]  
• O'Byrne, P. M. (2004). Pharmacologic Interventions to Reduce the Risk of Asthma Exacerbations. Proc Am Thorac Soc 1: 105-108 [Abstract] [Full Text]  
• Suissa, S., Baltzan, M., Kremer, R., Ernst, P. (2004). Inhaled and Nasal Corticosteroid Use and the Risk of Fracture. Am. J. Respir. Crit. Care Med. 169: 83-88 [Abstract] [Full Text]  
• Marcus, P. (2003). Dosing Inhaled Steroids in Asthma: Is Once-a-Day Administration Effective?. Chest 124: 1196-1198 [Full Text]  
• Campbell, J.L., Kiebert, G.M., Partridge, M.R. (2003). Development of the Satisfaction with Inhaled Asthma Treatment Questionnaire. Eur Respir J 22: 127-134 [Abstract] [Full Text]  
• Verona, E, Petrov, D, Cserhati, E, Hofman, J, Geppe, N, Medley, H, Hughes, S (2003). Fluticasone propionate in asthma: a long term dose comparison study. Arch. Dis. Child. 88: 503-509 [Abstract] [Full Text]  
• Green, R H, Brightling, C E, Pavord, I D, Wardlaw, A J (2003). Management of asthma in adults: current therapy and future directions. Postgrad. Med. J. 79: 259-267 [Abstract] [Full Text]  
• Suissa, S., Ernst, P. (2003). Use of anti-inflammatory therapy and asthma mortality in Japan. Eur Respir J 21: 101-104 [Abstract] [Full Text]  
• Lozano, P., Finkelstein, J. A., Hecht, J., Shulruff, R., Weiss, K. B. (2003). Asthma Medication Use and Disease Burden in Children in a Primary Care Population. Arch Pediatr Adolesc Med 157: 81-88 [Abstract] [Full Text]  
• Irvine, L., Crombie, I.K., Alder, E.M., Neville, R.G., Clark, R.A. (2002). What predicts poor collection of medication among children with asthma? A case-control study. Eur Respir J 20: 1464-1469 [Abstract] [Full Text]  
• Lynd, L. D., Guh, D. P., Pare, P. D., Anis, A. H. (2002). Patterns of Inhaled Asthma Medication Use: A 3-Year Longitudinal Analysis of Prescription Claims Data From British Columbia, Canada. Chest 122: 1973-1981 [Abstract] [Full Text]  
• Johnson, J. A., Majumdar, S. R., Simpson, S. H., Toth, E. L. (2002). Decreased Mortality Associated With the Use of Metformin Compared With Sulfonylurea Monotherapy in Type 2 Diabetes. Diabetes Care 25: 2244-2248 [Abstract] [Full Text]  
• Leigh, R., Vethanayagam, D., Yoshida, M., Watson, R. M., Rerecich, T., Inman, M. D., O'Byrne, P. M. (2002). Effects of Montelukast and Budesonide on Airway Responses and Airway Inflammation in Asthma. Am. J. Respir. Crit. Care Med. 166: 1212-1217 [Abstract] [Full Text]  
• Weinberger, M., Murray, M. D., Marrero, D. G., Brewer, N., Lykens, M., Harris, L. E., Seshadri, R., Caffrey, H., Roesner, J. F., Smith, F., Newell, A. J., Collins, J. C., McDonald, C. J., Tierney, W. M. (2002). Effectiveness of Pharmacist Care for Patients With Reactive Airways Disease: A Randomized Controlled Trial. JAMA 288: 1594-1602 [Abstract] [Full Text]  
• Soriano, J.B., Vestbo, J., Pride, N.B., Kiri, V., Maden, C., Maier, W.C. (2002). Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J 20: 819-825 [Abstract] [Full Text]  
• Suissa, S, Ernst, P, Kezouh, A (2002). Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma. Thorax 57: 880-884 [Abstract] [Full Text]  
• Barr, R. G., Somers, S. C., Speizer, F. E., Camargo, C. A. Jr (2002). Patient Factors and Medication Guideline Adherence Among Older Women With Asthma. Arch Intern Med 162: 1761-1768 [Abstract] [Full Text]  
• Lanes, S F, Garcia Rodriguez, L A, Huerta, C (2002). Respiratory medications and risk of asthma death. Thorax 57: 683-686 [Abstract] [Full Text]  
• Pinto Pereira, L. M., Clement, Y., Da Silva, C. K., McIntosh, D., Simeon, D. T. (2002). Understanding and Use of Inhaler Medication by Asthmatics in Specialty Care in Trinidad* : A Study Following Development of Caribbean Guidelines for Asthma Management and Prevention. Chest 121: 1833-1840 [Abstract] [Full Text]  
• Meltzer, E. O., Lockey, R. F., Friedman, B. F., Kalberg, C., Goode-Sellers, S., Srebro, S., Edwards, L., Rickard, K., Fluticasone Propionate Clinical Research Study Gro, (2002). Efficacy and Safety of Low-Dose Fluticasone Propionate Compared With Montelukast for Maintenance Treatment of Persistent Asthma. Mayo Clin Proc. 77: 437-445 [Abstract]  
• Allen;, D. B., Sharek, P. J., Bergman, D. A. (2001). Effect of Inhaled Corticosteroids on Growth. Pediatrics 108: 1234-1235 [Full Text]  
• Kips, J. C. (2001). Treating Asthma, or Is Simple Too Simple?. Am. J. Respir. Crit. Care Med. 164: 1336-1338 [Full Text]  
• Kozyrskyj, A. L., Mustard, C. A., Cheang, M. S., Simons, F. (2001). Income-based drug benefit policy: impact on receipt of inhaled corticosteroid prescriptions by Manitoba children with asthma. CMAJ 165: 897-902 [Abstract] [Full Text]  
• Kips, J C, Pauwels, R A (2001). Low dose inhaled corticosteroids and the prevention of death from asthma. Thorax 56: ii74-78 [Full Text]  
• SIN, D. D., TU, J. V. (2001). Inhaled Corticosteroids and the Risk of Mortality and Readmission In Elderly Patients with Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 164: 580-584 [Abstract] [Full Text]  
• Rabe, K.F., Schmidt, D.T. (2001). Pharmacological treatment of asthma today. Eur Respir J 18: 34S-40s [Abstract] [Full Text]  
• Eisner, M. D., Abramson, M., Bailey, M., Couper, F., Driver, J., Drummer, O., Forbes, A., McNeil, J., Walters, E. H., Victorian Asthma Mortality Study Group, t. (2001). INHALED BETA AGONISTS AND DEATH FROM ASTHMA: REVISITING THE CONTROVERSY. Am. J. Respir. Crit. Care Med. 163: 1502-1502 [Full Text]  
• Kelly, H. W. (2001). The Management of Acute Severe Asthma. Journal of Pharmacy Practice 14: 91-107 [Abstract]  
• Bourdet, S. V., Williams, D. (2001). Management Considerations for Chronic Asthma. Journal of Pharmacy Practice 14: 108-125 [Abstract]  
• Mapp, C. E. (2000). Inhaled Glucocorticoids in Chronic Obstructive Pulmonary Disease. NEJM 343: 1960-1961 [Full Text]  
• Myers, K. A. (2000). New evidence of a link between inhaled corticosteroid use and osteoporosis. CMAJ 163: 1335-1335 [Full Text]